Skip to content

Because every organ and tissue donation deserves the highest chance for success.

Every successful transplantation has decades of clinical research behind it — and countless donor heroes who selflessly said “yes” to life. Achieving a high success rate is the best way we can honor their gifts. Clinical research makes it possible.

Mid-America Transplant has long been a leader in clinical innovation for stewarding organ and tissue donations. In addition to research around improving heart quality, Dr. Marklin and Mid-America Transplant have published several industry-first innovations around lung and kidney donations that have led to even more lives saved.

“Rigorous clinical research can drive continuous improvement in organ donation.
By maximizing donation potential and
improving success rates in recipients, we
can be even greater stewards of the lifesaving gifts given to us by donor heroes
and their families.”

Dr. Gary F. Marklin, Chief Medical Officer at Mid-America Transplant

Since 2016, the Mid-America Transplant Foundation, through its Clinical Innovation Fund, has provided funding for research projects that seek to improve outcomes of organ and tissue donation and transplantation — and reduce the need for the thousands of people on the waitlist.

Grant applications will be accepted in 2026.

From innovation to community events, see what’s new at Mid-America Transplant

Until No One is Waiting

Mid-America Transplant

1110 Highlands Plaza Dr. East
Suite 100
St. Louis, MO 63110